Official recall notice

FDA DrugClass INotable

Thyroid Tablets Recall (Aug 2026) – Vitruvias Therapeutics

Product: Thyroid Tablets, USP 30 mg; Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.

Recall date
2026-08-24
Category
Drug
FDA class
Class I

Why it was recalled

Hazard

Potential for the Product to be Superpotent

One email a week when there are new recalls. Confirm by email; unsubscribe anytime.

Product description

Potential for the Product to be Superpotent

Affected products

Lot # 504950, Exp Date: 09/30/2026.

Verify with the official notice →
Share:

Related Recalls

2026-10-09 · FDA_DRUG
FDA Recall: Par Pharmaceutical: Brevital Sodium 500 mg/vial for Injection
Par Pharmaceutical
2026-10-01 · FDA_DRUG
FDA Recall: Greenwich: Glutathione Injection
Greenwich
2026-10-01 · FDA_DRUG
FDA Recall: Greenwich: Glutathione Injection
Greenwich
2026-09-30 · FDA_DRUG
FDA Recall: Walgreens Lubricant Eye Drops, Carboxymethylcellulose sodium 0.5%, Lubricant Eye Drops, Sterile, 0.5
Sterling Pharmaceutical Services LLC